These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 27428611

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Health economic assessment of universal immunization of toddlers against Hepatitis A Virus (HAV) in Mexico.
    Carlos F, Gómez JA, Anaya P, Romano-Mazzotti L.
    Hum Vaccin Immunother; 2016; 12(1):52-63. PubMed ID: 26503702
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cost-effectiveness of childhood hepatitis A vaccination in Argentina: a second dose is warranted.
    Ellis A, Rüttimann RW, Jacobs RJ, Meyerhoff AS, Innis BL.
    Rev Panam Salud Publica; 2007 Jun; 21(6):345-56. PubMed ID: 17761046
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Model-based projections of the population-level impact of hepatitis A vaccination in Mexico.
    Van Effelterre T, De Antonio-Suarez R, Cassidy A, Romano-Mazzotti L, Marano C.
    Hum Vaccin Immunother; 2012 Aug; 8(8):1099-108. PubMed ID: 22854667
    [Abstract] [Full Text] [Related]

  • 9. Public health impact and cost effectiveness of routine childhood vaccination for hepatitis a in Jordan: a dynamic model approach.
    Hayajneh WA, Daniels VJ, James CK, Kanıbir MN, Pilsbury M, Marks M, Goveia MG, Elbasha EH, Dasbach E, Acosta CJ.
    BMC Infect Dis; 2018 Mar 07; 18(1):119. PubMed ID: 29514609
    [Abstract] [Full Text] [Related]

  • 10. Public Health Impact and Cost-Effectiveness of Hepatitis A Vaccination in the United States: A Disease Transmission Dynamic Modeling Approach.
    Dhankhar P, Nwankwo C, Pillsbury M, Lauschke A, Goveia MG, Acosta CJ, Elbasha EH.
    Value Health; 2015 Jun 07; 18(4):358-67. PubMed ID: 26091589
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cost-effectiveness of routine catch-up hepatitis a vaccination in the United States: Dynamic transmission modeling study.
    Elbasha EH, Choi Y, Daniels V, Goveia MG.
    Vaccine; 2021 Oct 08; 39(42):6315-6321. PubMed ID: 34538694
    [Abstract] [Full Text] [Related]

  • 15. [Cost-utility analysis on universal childhood hepatitis A vaccination in regions with different anti-HAV prevalence rates of China].
    Pan XJ, Feng YM, Zhuang GH.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Aug 08; 33(8):862-6. PubMed ID: 22967346
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Economic evaluations of hepatitis A vaccination in middle-income countries.
    Suwantika AA, Yegenoglu S, Riewpaiboon A, Tu HA, Postma MJ.
    Expert Rev Vaccines; 2013 Dec 08; 12(12):1479-94. PubMed ID: 24168129
    [Abstract] [Full Text] [Related]

  • 18. Hepatitis A: the costs and benefits of the disease prevention by vaccine, Paraná, Brazil.
    Zahdi MR, Maluf I, Maluf EM.
    Braz J Infect Dis; 2009 Aug 08; 13(4):257-61. PubMed ID: 20231986
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.